Related Experiment Videos
Gender differences in risk factor control and treatment profile in diabetes: a study in 229 swedish primary health
Peter M Nilsson1, Holger Theobald, Gunilla Journath
1Department of Medicine, University Hospital, Malmö, Sweden. Peter.Nilsson@medforsk.mas.lu.se
Objective:
To measure the risk factors and treatment profile of diabetes patients treated in primary health care (PHC) in order to evaluate potential gender differences.
Design:
Cross-sectional survey of consecutive diabetes patients.
Setting:
229 PHC centres in Sweden.
Subjects:
5082 men and 4293 women with diabetes were investigated (1998-2001).
Main Outcome Measures:
Glycaemic control (HbA1c), blood pressure, lipid levels, prevalence of left ventricular hypertrophy and microalbuminuria. Proportions of patients with previous ischaemic heart disease (IHD) and specific drug treatment.
Results:
Male patients generally had better blood pressure ( < 140 and/or 85 mmHg) and glycaemic (HbA1c < 6.5%) control than corresponding female patients (44% and 59%, versus 40% and 54% in the 60-75 year age group; p < 0.01). Females showed higher levels of total (p < 0.01) and HDL cholesterol (p < 0.05) than males in all age groups. No gender difference was detected for LDL cholesterol levels in the younger or elderly patients, but in the age group 60-75 years female patients had significantly higher mean LDL cholesterol level than male patients (3.3 vs 3.2 mmol/L; p < 0.05). Previously known manifestations of IHD were more common (p < 0.01) in male patients.
Conclusion:
Elderly male patients with diabetes had a more favourable risk factor control than corresponding female patients.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology